주요서비스 바로가기
본문 바로가기
매체정보 바로가기
로그인 바로가기
기사검색 바로가기
전체서비스 바로가기
상단영역
UPDATE : 2024-04-19 17:10 (Fri)
Home
Log in
Join
전체메뉴
기사검색
검색
본문영역
Pharma
목록
(
총 :
2,226 )
기사목록 보기 형태
제목형
요약형
포토형
HK inno.N addresses growth concerns following patent suit setback
Kim Chan-hyuk
2024.03.12 16:25
‘Recognizing Enhertu’s innovative drug price will help Korean patients and industry’
Kim Yun-mi
2024.03.12 13:30
Korean biopharma firms to showcase latest research at US cancer meet AACR 2024
Lee Han-soo
2024.03.12 09:31
Hanmi Pharm applies for phase 1 trial of obesity drug HM15275
Kim Chan-hyuk
2024.03.11 16:21
ST Pharm, LegoChem Biosciences team up for ADC linker manufacturing, research
Lee Han-soo
2024.03.11 16:06
Keytruda approved as 1st-line treatment for HER2-negative gastric cancer to vie with Opdivo
Kim Chan-hyuk
2024.03.11 13:24
GSK's Jemperli beats MSD's Keytruda to become 1st-line treatment for endometrial cancer in Korea
Kim Chan-hyuk
2024.03.11 13:21
SK chemicals moves up 1 notch to ‘AA’ in MSCI ESG rating
Korea Biomedical Review
2024.03.11 11:33
Sanofi gets Korean license for invasive meningococcal vaccine MenQuadfi
Korea Biomedical Review
2024.03.11 11:13
Daehwa Pharm's Liporaxel Sol. wins orphan drug designation in Europe
Yang Hyeon-su
2024.03.08 16:12
GC Medical Science signs 5-year hemodialysis fluid supply accord with Baxter
Kim Chan-hyuk
2024.03.08 16:04
Genexine-Handok’s long-acting growth hormone gets ODD status in developmental stage
Kim Kyoung-Won
2024.03.08 15:15
처음
이전
이전
1
2
3
4
5
6
7
8
9
10
다음
다음
다음
끝
위로
전체메뉴
All
Hospital
Pharma
Bio
All
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
All
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
ASCO 2020 Highlights
Special Series in Celebration of KBR’s 4th Anniversary
KBR Covering RSNA 2021
Special Series in Celebration of KBR’s 5th Anniversary
Special Report on EULAR 2022
[Top K-Pharma Analysis]
BIO 2023
Opinion
All
Reporter’s Notebook
Journalist’s Column
Congratulatory Remarks
Sponsored
전체메뉴닫기